title: Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy.
authors.forename: R
authors.initials: R
authors.lastname: Longo
authors.forename: F
authors.initials: F
authors.lastname: Torino
authors.forename: A
authors.initials: A
authors.lastname: Morabito
authors.forename: S
authors.initials: S
authors.lastname: Amici
authors.forename: D
authors.initials: D
authors.lastname: Gattuso
authors.forename: L
authors.initials: L
authors.lastname: Manente
authors.forename: G
authors.initials: G
authors.lastname: Gasparini
mesh_terms: D000008:Abdominal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D018288:Carcinoma, Small Cell / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D000068818:Cetuximab; D019008:Drug Resistance, Neoplasm; D005076:Exanthema / Q000139:chemically induced; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000068818:Cetuximab